Archive

Gauteng’s medical negligence payouts soar 36%

Gauteng’s medical negligence payouts surged 36% to R696m in 2023/24, deepening the province’s healthcare crisis amid corruption scandals and systemic failures.

Read More

Health Minister must address causes of medical negligence

To reform SA’s troubled healthcare system, the Health Minister must tackle fraudulent claims and hold provincial health departments accountable.

Read More

Safeguarding medical scheme members amid economic challenges

The CMS Annual Report 2023/24 highlights its commitment to protecting medical scheme members, achieving 86% of strategic goals, and resolving 93% of complaints.

Read More

Duo bag Nobel prize for medicine for discovery of microRNA

US scientists Victor Ambros and Gary Ruvkun won the 2024 Nobel Prize in Medicine for discovering microRNA’s crucial role in gene regulation, cell development.

Read More

Substantial contribution hikes could bolster NHI support

Bestmed warns that rising medical scheme contributions risk alienating younger members and bolstering NHI support. Bestmed proposes a 12.75% increase.

Read More

Closure of drug rehab centres leaves many without support

The closure of Life Nkanyisa’s drug rehab centres in Gauteng leaves a significant gap in substance abuse treatment for over 600 patients.

Read More

Rising rates of cancer in young adults: A concerning trend

This rise is part of a broader trend in early-onset cancers, including breast and pancreatic cancers, sparking serious concerns among global health experts.

Read More

HIV treatment success: Sustaining lifelong care is key

People with HIV on treatment can expect a similar life expectancy as the HIV-negative. Addressing treatment disengagement is vital to ending HIV transmission.

Read More

WHO approves first emergency use Mpox diagnostic test

WHO approves Abbott’s Alinity m mpox diagnostic test for emergency use, enhancing testing in outbreak regions. The PCR test detects the virus from skin swabs.

Read More

Nkengasong calls for collaboration to secure ARV production

Pepfar’s role in boosting local ARV production in Africa, ensuring stable market demand and global acceptance.

Read More

Thoughts on health systems and the future of NHI

Professor Lucy Gilson offers insights into health systems, human relationships, the impact of the NHI Act, and her vision for improving healthcare in SA.

Read More

Gilead grants licenses for generic HIV drug production

Gilead Sciences has granted royalty-free licenses to six generic drug manufacturers for the HIV prevention drug lenacapavir in 120 low-income countries.

Read More